Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions

scientific article published in January 1993

Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00204625
P698PubMed publication ID8362342

P2093author name stringA W Ford-Hutchinson
P2860cites workIdentification of a human gamma-glutamyl cleaving enzyme related to, but distinct from, gamma-glutamyl transpeptidaseQ24293328
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesisQ24299373
Evaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenaseQ28242585
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsQ68293935
Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4Q68484069
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonistQ68487207
The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in manQ68518136
The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry airQ68613879
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonistQ69343462
The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjectsQ69838847
Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolaseQ70097113
Human 5-lipoxygenase contains an essential ironQ70163897
Inhibition of leukotriene C and leukotriene D biosynthesisQ72430373
Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytesQ72940777
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responsesQ72963149
Slow reacting substance and related compoundsQ79357743
Human leukotriene C4 synthase expression in dimethyl sulfoxide-differentiated U937 cellsQ28264329
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAPQ28302244
Purification of human leukotriene C4 synthase from dimethylsulfoxide-differentiated U937 cellsQ28317185
Lung function improvement in asthma with a cysteinylleukotriene receptor antagonistQ28322631
Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytesQ28342930
Leukotriene C: a slow-reacting substance from murine mastocytoma cellsQ33972104
Molecular cloning of a cDNA coding for human leukotriene A4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesis.Q34186608
Liberation of histamine and formation of lysocithin-like substances by cobra venomQ34568156
Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patientsQ36241039
Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4Q36270108
Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic responseQ36348698
Leukotriene D: a slow reacting substance from rat basophilic leukemia cellsQ36363644
Leukotriene B4 in inflammation.Q37873024
Leukotriene receptor antagonists as potential therapeutic agentsQ38272493
Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthmaQ41085264
Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorQ41137843
Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradationQ41182690
Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.Q41199570
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthmaQ41273463
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorQ42119720
Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthmaQ42126419
Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reactionQ42161966
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonistQ42206200
The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).Q42272808
The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.Q43648861
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorQ45227226
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571Q46209751
Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078.Q46233704
Leukotriene B: a potential mediator of inflammationQ46329837
FLAP: a novel drug target for inhibiting the synthesis of leukotrienesQ46393647
The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonistQ46786376
Structure of slow-reacting substance of anaphylaxis from guinea-pig lungQ46852072
5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitorsQ46967003
MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the humanQ49122118
L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist.Q53884882
Leukotrienes: potent mediators of airway constriction.Q53905232
The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.Q54407306
Identification and isolation of a membrane protein necessary for leukotriene productionQ59059824
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesQ59077242
Leukotriene B4 induces human suppressor lymphocytesQ67253442
MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytesQ67267224
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitorsQ67492647
5-lipoxygenase inhibitory activity of zileutonQ67914330
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthmaQ67995623
Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibitionQ68129408
Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Comparison and interaction with methacholineQ68193088
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)37-50
P577publication date1993-01-01
P1433published inSeminars in ImmunopathologyQ15724576
P1476titleLeukotriene antagonists and inhibitors as modulators of IgE-mediated reactions
P478volume15

Reverse Query: null

Search more.